Affiliation:
1. Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
2. Department of Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China
Abstract
Background: Prostate cancer (PCa) is the leading cause of death in men and has poor therapeutic outcomes. Methods: A novel endostatin 33 peptide was synthesized by adding a specific QRD sequence on the basis of the endostatin 30 peptide (PEP06) with antitumor activity. Then, bioinformatic analysis and subsequent experiments were performed to validate the antitumor function of this endostatin 33 peptide. Results: We found that the 33 polypeptides significantly inhibited growth, invasion and metastasis and promoted the apoptosis of PCa in vivo or vitro, which is more significant than PEP06 under the same conditions. According to 489 cases from the TCGA data portal, the α6β1 high expression group was closely associated with the poor prognosis (Gleason score, pathological N stage, etc.) of PCa and was mainly enriched in the PI3K-Akt pathway. Subsequently, we demonstrated that endostatin 33 peptide can down-regulate the PI3K-Akt pathway via the targeted inhibition of α6β1, thereby inhibiting the epithelial–mesenchymal transition and matrix metalloproteinase in C42 cell lines. Conclusion: The endostatin 33 peptide can exert antitumor effects by inhibiting the PI3K-Akt pathway, especially in tumors with a high expression of the integrin α6β1 subtype, such as prostate cancer. Therefore, our study will provide a new method and theoretical basis for the treatment of prostate cancer.
Funder
Natural Science Foundation of Heilongjiang Province
Heilongjiang Renxin Medical Assistance Foundation
Reference32 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019
2. Risk Stratification in Hormone-sensitive Metastatic Prostate Cancer: More Questions than Answers;Psutka;Eur. Urol.,2015
3. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth;Boehm;Cell,1997
4. αvβ3 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin;Wang;Mol. Cancer Res.,2019
5. Nieberler, M., Reuning, U., Reichart, F., Notni, J., Wester, H.-J., Schwaiger, M., Weinmüller, M., Räder, A., Steiger, K., and Kessler, H. (2017). Exploring the Role of RGD-Recognizing Integrins in Cancer. Cancers, 9.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献